Stay updated on Pembrolizumab Combo With Local Ablation in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.

Latest updates to the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter shows Revision: v3.3.2 replacing v3.2.0. There are no changes to the study details, eligibility criteria, or results on the page.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the site-wide funding/operating-status banner. The study details, eligibility criteria, and results information on this page remain unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant updates were detected on the page; the study details, inclusion criteria, and planned interventions remain as published. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated to reflect current operating status and official references; version bumped from v3.1.0 to v3.2.0.SummaryDifference2%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.0.2 replaces v3.0.1, signaling a new release; the Back to Top element has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo With Local Ablation in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.